ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
bullish•Celltrion Inc
•21 May 2021 14:02

Celltrion Merger Situation & Long/Short on the Celltrion Duo

This post discusses the planned merger situation and explores a long/short trade on Celltrion and Celltrion Healthcare as the relative valuation...

Logo
466 Views
Share
bearish•Pearl Abyss
•21 Feb 2021 16:19

KRX BBIG K-NewDeal Index Rebalance: First Set of Changes Announced

The KRX has announced changes to the KRX New Deal indices that will be effective after the close of trading on 25 February. Pearl Abyss is...

Logo
635 Views
Share
•06 Feb 2021 05:52

Asia Short Interest: Cathay, PSBC, BYD, CNOOC, Bandai Namco, Anritsu, Celltrion, HLB, Fitipower

The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
468 Views
Share
bearish•Celltrion Inc
•03 Feb 2021 14:26

Korea Short Sell Ban: Elections, Public Outrage, Bus Tours, Blue House Petitions, K-Streetbets

With the short sell ban in Korea scheduled to expire 15 March, we look at stocks that have seen the most short covering since the start of the ban,...

Logo
584 Views
Share
•09 Nov 2020 02:59

Celltrion Pair: Entry Point on Latest Diversion

Celltrion H is at -2σ for the first time since early July. I expect a quick reversion: the COVID-19 vaccine and block deal risk are a neutral...

Logo
263 Views
Share
x